Navigation Links
Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology
Date:4/20/2009

- Findings Demonstrate Survival Benefit with Picoplatin as Second-Line Therapy for Small Cell Lung Cancer -

SOUTH SAN FRANCISCO, Calif., April 20 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that results of its Phase 2 clinical trial of picoplatin in patients with recurrent small cell lung cancer (SCLC) were published in the April 20, 2009, print issue of the Journal of Clinical Oncology(1). Picoplatin demonstrated a survival benefit in this open-label, multi-center Phase 2 trial of SCLC patients who failed prior platinum-containing first-line chemotherapy or who progressed within six months of first-line therapy. The median overall survival was 27 weeks and the median one-year survival rate was 17.6 percent in this patient population of mostly platinum-refractory and -resistant patients.

Poniard is currently evaluating the efficacy and safety of picoplatin in the pivotal Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) SCLC trial, which is being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA). The Company reached its enrollment target in this international, multi-center, randomized, controlled trial in March 2009.

SCLC is the most aggressive lung cancer and tends to be widely disseminated by the time of diagnosis. The prognosis for patients with SCLC that has progressed despite chemotherapy is exceedingly poor regardless of stage. Effective second-line treatment for SCLC is a major unmet need. There is no standard chemotherapy for second-line platinum-refractory or -resistant SCLC.

"New treatments are desperately needed for patients with platinum-resistant and -refractory small cell lung cancer due
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
3. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
4. Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin
5. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
6. Poniard Pharmaceuticals Receives Going Concern Qualification
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... 18, 2014) Benaroya Research Institute at Virginia Mason ... a particular molecule in metastatic breast cancer reduces both ... lung metastases. BRI scientists have found in models of ... by 60 - 80 percent and can keep the ... $1.8 million five-year grant comes from the National Cancer ...
(Date:4/17/2014)... presence of chronic inflammation in benign prostate tissue ... and this association was found even in those ... a study published in Cancer Epidemiology, Biomarkers ... Association for Cancer Research. , An analysis of ... the placebo arm of the Prostate Cancer Prevention ...
(Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
(Date:4/17/2014)... Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, was ... April issue of Nature Reviews Microbiology , ... Dr. McCullers, a world-renowned infectious disease specialist, and ... University of Tennessee Health Science Center, analyzed the ... 1957 and 1968 pandemics, as well as more ...
(Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Is Parkinson's an autoimmune disease? 2
... software that helps you work smarter by communicating visually, is becoming ... document and standardize processes across hospital departments in order to meet ... ... 26, 2009 -- SmartDraw.com, maker of SmartDraw, the software that helps ...
... that good lifestyle choices help prevent diabetes type 2CHICAGO, March ... offense is a good defense - in football and in ... about diabetes in his own family. "Seeing my mother lose ... bit. I think about all the things Mom could have ...
... G. Komen for the Cure(R) Advocacy Alliance applauds the ... Bailey Hutchison (R-TX) to reignite the war on cancer ... ALERT ( A ccess to L ife-saving ... reatment) Act. (Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO )"It,s been ...
... March 26 /PRNewswire-HISPANIC PR WIRE/ -- Pfizer,Helpful Answers ... years ago in partnership with the Dallas Concilio ... San Antonio and Corpus Christi gain,greater access to ... train five community health workers - promotores - ...
... in inpatient practice management, announces growth in leadership in ... (IM) recently appointed two additional members to serve on ... in conjunction with a new CEO and increased staff.Mark ... over 20 years of entrepreneurial, financial and operational leadership ...
... Elizabeth Espinoza and Mark Williams Named National Epilepsy Spokespersons ... Mark Williams, siblings from Hutto, TX will travel to ... 2009 to meet with congressional leaders and gain their ... toward a cure for epilepsy as part of the ...
Cached Medicine News:Health News:SmartDraw Helps Hospitals Document and Standardize Processes to Achieve Greater Compliance With Regulatory Agencies 2Health News:SmartDraw Helps Hospitals Document and Standardize Processes to Achieve Greater Compliance With Regulatory Agencies 3Health News:Blue Cross and Blue Shield of Illinois Teams with Chicago Bears Coach Lovie Smith in Diabetes Awareness Drive 2Health News:Blue Cross and Blue Shield of Illinois Teams with Chicago Bears Coach Lovie Smith in Diabetes Awareness Drive 3Health News:Blue Cross and Blue Shield of Illinois Teams with Chicago Bears Coach Lovie Smith in Diabetes Awareness Drive 4Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Senators Kennedy, Hutchison for Bipartisan Cancer Alert Act 2Health News:March 22-28 is Cover the Uninsured Week 2Health News:March 22-28 is Cover the Uninsured Week 3Health News:Ingenious Med Expands Leadership and Adds Members to Board of Directors 2Health News:Ingenious Med Expands Leadership and Adds Members to Board of Directors 3Health News:Texas Siblings Share Epilepsy Message on Capitol Hill 2
(Date:1/15/2014)... Texas , Jan. 15, 2014  Novation, the leading ... awarded several new IT value-added reseller (VAR) national contracts ... IT goods and services at lower costs. These include ... services such as initiative assistance and ongoing IT consulting ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... anti-mail-service pharmacy legislation, New York Governor Andrew Cuomo announced ... to amend NY AB 5502-B, which prevents employers from ... cost mail-service pharmacy option. "Employers, taxpayers, ... to improve this costly, anti-consumer bill," said Pharmaceutical ...
... RIDGE, Colo., Dec 13, 2011 MedEfficiency, Inc., ... the development, manufacturing, and marketing of medical devices ... today announced that it has been awarded a ... contract, MedEfficiency will be listed as a government-approved ...
Cached Medicine Technology:PCMA: Governor Cuomo's Call to Amend Anti-Mail-Service Pharmacy Law Protects Employers and Consumers 2PCMA: Governor Cuomo's Call to Amend Anti-Mail-Service Pharmacy Law Protects Employers and Consumers 3MedEfficiency Awarded VA Contract for Its Total Contact Casting Products 2
TEW serrated micro-retractor blade set....
Micro-retractor arm 12"....
The Budde Halo Retractor Side Rail Support is designed for the adaptation and attachment of the Budde Halo Brain Retractor System to the operating room table when a conventional skull clamp is not us...
Epstein Curettes 3.0 mm, length 8" (203 mm)....
Medicine Products: